Abstract: A power storage module includes: a stack including power storage cells stacked in a first direction and having stack side surfaces that extends in the first direction; and a sealing member formed in contact with the stack side surfaces. The power storage cells each includes: a first electrode including a first electrode plate having a first surface and a first active material layer formed on the first surface; a second electrode including a second electrode plate having a second surface and a second active material layer having an electrode polarity different from that of the first active material layer and formed on the second surface; and a spacer. A portion of the sealing member disposed on at least one of the stack side surfaces serves as a low elastic modulus portion that has an elastic modulus lower than that of the spacer.

Abstract: A power storage device includes power storage cells that includes a positive electrode, a negative electrode, a separator, and an accommodation chamber accommodating a liquid electrolyte in a liquid-tight manner. The power storage device includes a cell stack in which the power storage cells are stacked in series. A side surface of the cell stack is covered with a seal portion made of a plastic. The terminal positive electrode current collector and the terminal negative electrode current collector located in the outermost layer of the cell stack are made of a high thermal conductivity material having a thermal conductivity greater than or equal to 100 W/(m·K). The power storage device includes a positive electrode cooling unit, which cools the terminal positive electrode current collector, and a negative electrode cooling unit, which cools the terminal negative electrode current collector. The liquid electrolyte contains an oxalate compound.

Abstract: A power storage device includes power storage cells that includes a positive electrode, a negative electrode, a separator, and an accommodation chamber accommodating a liquid electrolyte in a liquid-tight manner. The power storage device includes a cell stack in which the power storage cells are stacked in series. A side surface of the cell stack is covered with a seal portion made of a plastic. A terminal positive electrode current collector and a terminal negative electrode current collector located in the outermost layer of the cell stack are made of a high thermal conductivity material having a thermal conductivity greater than or equal to 100 W/(m·K). The power storage device includes a positive electrode cooling unit, which cools the terminal positive electrode current collector, and a negative electrode cooling unit, which cools the terminal negative electrode current collector. The liquid electrolyte contains an ester compound.

Abstract: Provided is a condensed polycyclic aromatic compound, having lithium ion responsivity and is suitable for lithium ion secondary battery applications, a production process thereof, a positive electrode active material containing that condensed polycyclic aromatic compound, and a positive electrode for a lithium ion secondary battery provided therewith, and further provided is a lithium ion secondary battery, having high capacity and cycling adaptability, that has the positive electrode as a constituent thereof. The condensed polycyclic aromatic compound has at least four imino groups in a molecule thereof.

Abstract: The present invention provides a compound of formula (I): wherein the variants R1, R2, R3, R4, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.

Abstract: In a lithium-ion secondary battery using a positive-electrode active material that includes a lithium-manganese-based oxide which includes a lithium (Li) element and a tetravalent manganese (Mn) element and whose crystal structure belongs to a layered rock-salt structure, adding a compound being selected from the group consisting of Compounds (a) through (i) into the electrolytic solution leads to the following: degradations due to oxidation-reduction decompositions of the electrolytic solution, and so on, are inhibited; and not only the shelf or storage capacity and recovered capacity upgrade in the case of being stored at high temperatures, but also the rise of internal resistance is inhibited.

Abstract: There are provided compounds of formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as indicated in claim 1 , useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.

Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.

Abstract: Provided is a condensed polycyclic aromatic compound, having superior lithium ion responsivity and is suitable for lithium ion secondary battery applications, a production process thereof, a positive electrode active material containing that condensed polycyclic aromatic compound, and a positive electrode for a lithium ion secondary battery provided therewith, and further provided is a lithium ion secondary battery, having high capacity and superior cycling adaptability, that has the positive electrode as a constituent thereof. The condensed polycyclic aromatic compound according to the present invention has at least four imino groups in a molecule thereof.

Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.

Abstract: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.

Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them

Abstract: There are provided compounds of formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as indicated in claim 1, useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.

Abstract: Novel pyrimidine derivatives of formula I to process for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Abstract: There are provided compounds of formula I wherein X, R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as indicated in claim 1, useful in disorders where ZAP-70 and/or Syk inhibition plays a role or caused by a malfunction of signal cascades connected with FAK.

Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Abstract: Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them.

Abstract: The present invention provides a compound of formula (I): wherein the variants R1, R2, R3, R4, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.

Abstract: A high-elasticity biodegradable polymer comprising PDC, which has excellent solubility in solvents and reactants, in their repeating unit structures is provided in an inexpensive manner. A polymer comprising a repeating unit represented by the following formula (I): wherein R1 and R2 each independently represent a divalent hydrocarbon residue with no active hydrogens in its structure and optionally containing a heteroatom; X represents O or NH; x represents an integer of at least 1; and m and n represent 0 or 1; and a process for their production.